These findings significantly expand our fundamental scientific understanding of age-related retinal diseases while offering potential new biomarkers ...

The global Age-Related Macular Degeneration (AMD) Market is poised for significant expansion over the next decade, with its value expected to grow from US$ 11.31 billion in 2023 to US$ 19.72 billion ...

It's natural for your vision to shift over time. Here are simple ways to care for your eyes, especially this bright, sunny ...

David A. Eichenbaum, MD, FASRS, is a board-certified ophthalmologist and fellowship-trained retina specialist. He is a partner and Director of Research at Retina Vitreous Associates of Florida ...

An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 ...

Eyestem Research announced positive results from its phase 1 trial ( NCT06394232) evaluating its investigational drug product ...

Discover the warning signs and treatment options for myopic macular degeneration, a serious eye condition affecting people ...

The announcement follows the decision to discontinue the COAST and ShORe trials in wet age-related macular degeneration after ...

4月2日，亿胜生物科技有限公司（“亿胜生物”或“集团”，股票代码：1061.HK）宣布，集团与上海复宏汉霖生物技术股份有限公司（“复宏汉霖”，股票代码：2696.HK）合作开发的重组抗血管内皮生长因子（Vascular endothelial growth ...

【财华社讯】复宏汉霖 (02696.HK)公布，近日，重组抗VEGF人源化单克隆抗体注射液HLX04-O在一项于湿性年龄相关性黄斑变性 (wet age-related macular ...